🌍Wholesale for resellers — now available worldwide · 30-vial minimum order
Free EU shipping over €200 · For research use only
⚡ Fast checkout · ships in 48h Pay Pay VISA
10‑vial kitFat lossRetaNord Tirzepatide research peptide — 10-vial kit
Dual agonist Metabolic · GIP / GLP-1

Tirzepatide

Dual GIP / GLP-1 receptor agonist · 10-vial research kit

Engineered incretin peptide · dual GIP + GLP-1 agonist

Tirzepatide is a synthetic incretin peptide that activates two metabolic receptors — GIP and GLP-1 — in a single molecule. It is one of the most widely studied dual-agonist compounds in current metabolic research.

€48910 mg · 10-vial kitIn stock

Each kit is 10 identical vials. Minimum 1 kit (10 vials) to the EU · 3 kits (30 vials) to the US. Free EU shipping.

Plain, unbranded packaging. No product names, no logos — nothing on the outside indicating what is inside. Tracked to a DPD Locker or your address.

Purity 99%+ HPLC
Kit 10 vials
Ships in 24h

For laboratory and in vitro research use only. Not for human or veterinary use, and not for use in diagnostic procedures.

Stocked & shipped in the EUDispatched in 24hFree EU shippingSold in 10-vial kitsSealed, lyophilized vials

About Tirzepatide

Tirzepatide is a synthetic 39–amino-acid peptide engineered as a dual agonist of the GIP and GLP-1 receptors, with a fatty-acid modification that extends its plasma half-life. It sits alongside semaglutide and retatrutide in the incretin class that dominates today's metabolic and obesity research.

RetaNord supplies Tirzepatide as a fixed kit of 10 lyophilized vials, each verified at 99%+ identity purity by HPLC with identity confirmed by mass spectrometry. Supplied for laboratory and in vitro research use only.

Specifications

CategoryFat Loss & Metabolic
Compound classSynthetic peptide — dual GIP/GLP-1 agonist
Presentation10 vials per kit · lyophilized
Available sizes5 · 10 · 15 · 20 · 30 · 40 · 50 · 60 mg per vial
Identity purity99%+ (HPLC)
Identity confirmationMass spectrometry
Storage2–8°C; −20°C long term

Tirzepatide — questions

What is tirzepatide studied for?

In published research it is characterised as a dual GIP/GLP-1 receptor agonist and studied in metabolic and body-weight contexts. RetaNord supplies it strictly for laboratory research use — not as a medicine.

Why is this sold as a 10-vial kit?

These research compounds are supplied in fixed kits of 10 identical vials — the standard research quantity. One kit (10 vials) is the minimum order to the EU; 30 vials (3 kits) is the minimum to the US.

Documented peptides, shipped from the EU.

Every RetaNord kit ships within 24 hours, discreetly packaged and tracked, from within the EU. For laboratory research use only.

Order this kit
€489Order